Watchlist

Watchlist
Aquinox Pharmaceuticals, Inc. (AQXP)
Aquinox Pharmaceuticals, Inc. (AQXP)
Your Daily Pharma Scoop: Synergy's New CEO, AbbVie Data, TiGenix Changes
Content Analysis of coverage: SGYP Stocks in the news: ABBV, TIG, EGLT Analyst Ratings Insider Sales Insider Purchases Secondary Offerings Earnings Report Earnings Calendar Analysis of top Seeking Alpha coverage: Synergy Pharmaceuticals Today …
Your Daily Pharma Scoop: Omeros Potential, Portola's Setback, Proteostasis Soars
Content Analysis of coverage Stocks in the news Analyst Ratings Insider Sales Insider Purchases Earnings Report Secondary Offerings Earnings Calendar TPT subscribers only Trade Idea of the Day Subscriber Questions & Answers Catalyst Ru…
Biotech Forum Daily Digest: Revisiting Neos Therapeutics
"He had just about enough intelligence to open his mouth when he wanted to eat, but certainly no more." - P.G. Wodehouse The main biotech indices rose some two percent on Friday to close the week relatively flat. Most of the early part of the week we saw weakness across the biotech sector,…
Nasdaq Biotech Index: 54 to be added, 15 removed
Changes will become effective prior to the open next Monday. ETF: IBB More news on: iShares Nasdaq Biotechnology ETF, Arbutus Biopharma Corp, Aclaris Therapeutics, Healthcare stocks news, News on ETFs, Read more …
Stocks to watch next week
Coming soon: Subscribe to Stocks to Watch every week in article format. Check this space next week for details More news on: Quanterix Corp., Odonate Therapeutics, Curo Group, Consumer stocks news, Tech stocks news, Financial stocks news, Healthcare stocks news, News on ETFs, Read m…
Healthcare events next week
Upcoming events in healthcare next week: More news on: Zogenix, Inc., Omnicell, Inc., Ultragenyx Pharmaceutical Inc., Healthcare stocks news, Read more …
A Current Look At The ROTY Contenders List
ROTY (Runners of the Year) is a strategy which involves two parts, the official 10 stock model account and our Contenders List of ideas. Basically, we are looking for stocks that could outperform (ideally double or more) within the near to medium term (next quarter to 12 months out). While the…
Aquinox Pharmaceuticals: Expecting A Rebound In 2018
Shares of Aquinox Pharmaceuticals ( AQXP ) have fallen by over 30% since my April 4th article in which I stated my expectation that patience on the part of investors would be rewarded. AQXP data by YCharts Keys to the original bullish thesis included the following: Management appeare…
ROTY Volume 1 Edition 27: Spring Bank And Anaptysbio Making Moves Higher + A New Pilot Purchase
Welcome to the 27th entry in our Runner of the Year (ROTY) series. Our model account utilizes a full position size of $10,000 and can hold up to 10 positions. Trades typically occur in quarter increments ($2,500) with cost averages calculated at the day's close. The model account is primaril…
Aquinox Pharmaceuticals: Buy, Sell Or Hold?
Believing passionately in the palpably not true… is the chief occupation of mankind . - H.L. Mencken I have gotten two questions this week on a small Canadian biopharma concern in the crowded pain management sector. Given this, I am going to post a previously exclusive "deep d...
ROTY Volume 1 Edition 25: Swapping Out Weakness For Strength
Welcome to the 25th entry in our Runner of the Year (ROTY) series. Our model account utilizes a full position size of $10,000 and can hold up to 10 positions. Trades typically occur in quarter increments ($2,500) with cost averages calculated at the day's close. The model account is primaril…
Aquinox Pharmaceuticals, Inc. (AQXP)